Trials / Unknown
UnknownNCT04922385
Cognitive Behavioural Therapy for Sexual Concerns During Perimenopause
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- St. Joseph's Healthcare Hamilton · Academic / Other
- Sex
- Female
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Given the high rates and associated impairment of sexual concerns during the menopausal transition, and specifically during perimenopause, our team has developed a CBT protocol specifically designed to target these prevalent and distressing sexual concerns. The broad aim of the proposed study is to validate this new protocol in a clinic that provides empirically-supported assessment and intervention services for women with menopause-related symptoms. The primary objective of this study is to evaluate the efficacy of a four-week individual CBT protocol in improving sexual satisfaction and reducing distress during perimenopause. The secondary objective of this study is to evaluate the efficacy of this CBT protocol to improve sexual functioning (e.g., desire, arousal), relationship satisfaction, and body image. Exploratory analyses will examine the impact on this CBT protocol on vasomotor symptoms, depression, and anxiety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cognitive Behavioural Therapy | This study is an open waitlist control study. Eligible participants will be assigned to a treating clinician and will complete 4 weeks of treatment, followed by a post-treatment assessment (2 weeks later). If a treating clinician is not immediately available, participants will be placed on their waitlist for 4 weeks. They will then be assessed after 4 weeks and undergo the 4 week treatment, followed by the post-treatment assessment (2 weeks later). |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2021-06-10
- Last updated
- 2022-08-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04922385. Inclusion in this directory is not an endorsement.